- Exchange: OTC US
- Sector: Health Care
- Industry: Health Care Facilities & Svcs
- Sub-Industry: Health Care Services
Interleukin Genetics Inc+ Add to Watchlist
ILIU:US0.1490 USD 0.0010 0.67%
As of 20:10:00 ET on 02/27/2015.
Company Profile for Interleukin Genetics Inc (ILIU)
Interleukin Genetics, Inc. develops and commercializes genetic diagnostic tests and medical research tools. The Company's PST, a test predictive of risk for periodontal disease, is currently available in the United States. Interleukin also develops and licenses its medical research tools, such as BioFusion, to pharmaceutical companies for use in drug discovery and development.
Interleukin Genetics Inc
Key Executives for Interleukin Genetics Inc (ILIU)
|Kenneth S Kornman "Ken"Pres/CEO/Chief Scientific Ofcr||Stephen J DipalmaInterim CFO|
|Scott A SnyderChief Marketing Officer|